Lilly and AstraZeneca Expand Immuno-Oncology Research Collaboration with New Combinations
Go back to Lilly and AstraZeneca Expand Immuno-Oncology Research Collaboration with New Combinations| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 3,817,855 | |||||
| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 3,817,855 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1280.34 +54.61 (4.46%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1225.73 | 52 Week High | $88.16 | |||
| Open | $1245.81 | 52 Week Low | $67.88 | |||
| Day High | $1292.65 | P/E | 296.38 | |||
| Day Low | $1240.54 | EPS | $4.32 | |||
| Volume | 4,541,336 | |||||

